CD4 and autoimmune uveitis: Modulating the oxidation of LCFAs and SCFAs in CD4+ T cells also holds promise for the treatment of autoimmune uveitis and ERU by regulating the Th17/Treg balance, potentially enhancing the immunoregulatory effects of Tregs [10,15,59].